Page last updated: 2024-10-24

buspirone and Akinetic-Rigid Variant of Huntington Disease

buspirone has been researched along with Akinetic-Rigid Variant of Huntington Disease in 3 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Research Excerpts

ExcerptRelevanceReference
"or s."5.72The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022)
"or s."1.72The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat. ( Depoortere, R; Jastrzębska-Więsek, M; Kołaczkowski, M; Newman-Tancredi, A; Varney, MA; Wesołowska, A, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Jastrzębska-Więsek, M1
Wesołowska, A1
Kołaczkowski, M1
Varney, MA1
Newman-Tancredi, A1
Depoortere, R1
Byrne, A1
Martin, W1
Hnatko, G1
Hamner, M1
Huber, M1
Gardner, VT1

Other Studies

3 other studies available for buspirone and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
The selective 5-HT 1A receptor agonist, NLX-112, overcomes tetrabenazine-induced catalepsy and depression-like behavior in the rat.
    Behavioural pharmacology, 2022, 08-01, Volume: 33, Issue:5

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Buspirone; Catalepsy; Depres

2022
Beneficial effects of buspirone therapy in Huntington's disease.
    The American journal of psychiatry, 1994, Volume: 151, Issue:7

    Topics: Aggression; Buspirone; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged

1994
Patient with progressive dementia and choreaothetoid movements treated with buspirone.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:3

    Topics: Anti-Anxiety Agents; Buspirone; Humans; Huntington Disease; Male; Middle Aged

1996